MATRICELF LTD

General Data

Reg Number
516016037
Sector
Biomed
Established
2019
No. of Employees
15
Stage
R&D
Additional Funding
0

Description

Matricelf’s novel regenerative medicine platform aims to cure a range of medical conditions , currently focusing on Spinal Cord Injuries (SCI)

Technology

Proprietary autologous 3D tissue engineering platform.

Targeted Customers

Healthcare & Biotechnology sectors, including regenerative medicine and cell-based therapies; Patients with spinal cord injuries and other severe tissue damage; Potential broader markets: neurological injuries, cardiovascular damage, trauma care.

Management personnel

Gil Hakim - CEO
Sigal Russo - CFO

Contact information

Name
Tamar Harel Adar
Phone
0528353002
Website
http://www.matricelf.com
Country
Israel
Zip
7403648

Tags

3D PrintingBio PrintingBiotechnologyCell TherapyImplantsLife SciencesNervesNeuroscienceRegenerative MedicineSpinal Cord InjuryStem CellsTissue Engineering

Winning details

Route name
Winning year

Increasing participation of Israeli industrial corporations in the European Horizon program
Increasing participation of Israeli industrial corporations in the European Horizon program
2024